Erlotinib can halt adenine induced nephrotoxicity in mice through modulating ERK1/2, STAT3, p53 and apoptotic pathways
Abstract Renal fibrosis is a failed regenerative process that facilitates chronic kidney disease progression. The current study was designed to study the effect of erlotinib, a receptor tyrosine kinase inhibitor, on the progression of renal fibrosis. The study included four groups of mice: control g...
Guardado en:
Autores principales: | Ahmed M. Awad, Mohamed A. Saleh, Nashwa M. Abu-Elsaad, Tarek M. Ibrahim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/560d2b0d40c445388b9d8934e613639a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.
por: Jasmine G Lee, et al.
Publicado: (2012) -
Erlotinib in the treatment of advanced pancreatic cancer
por: Robin K Kelley, et al.
Publicado: (2008) -
Novel strategies halt cardiovascular, diabetes, and cancer strips
por: Chun-Song Hu, et al.
Publicado: (2017) -
Sexual selection halts the relaxation of protamine 2 among rodents.
por: Lena Lüke, et al.
Publicado: (2011) -
Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?
por: Yasemin Coşkun Yavuz, et al.
Publicado: (2021)